Akava Therapeutics Inc.
New Filing
CIK: 0001966649·Pharmaceuticals·DELAWARE·Filed: Feb 21, 2025
Total Offering
$500,000
Amount Sold
$100,000
Investors
1
First Sale
Feb 5, 2025
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Richard Silverman | Related Person |
| Philip Silverman | Related Person |
| Brendan MacMillan | Related Person |
| Joseph Nolan | Related Person |
| Charles V Polsky | Related Person |
Company
SEC Filing
0001966649-25-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free